Greater Manchester rejects Palantir NHS platform, fueling debate over $400M contract
This digest was compiled by AI from multiple sources — links to the originals are below.
Greater Manchester's NHS board has repeatedly declined to adopt Palantir's Federated Data Platform, citing trust and functionality concerns. The decision has intensified a national debate over whether the UK government should terminate its $400 million contract with Palantir early. The NHS has until February 2027 to decide on early termination, even as Palantir and NHS England claim the platform is already reducing wait times and hospital stays.
Key Facts
- The UK government has six months to decide whether to terminate its NHS contract with Palantir, worth more than $400 million.
- Greater Manchester's NHS board has repeatedly declined to adopt Palantir's Federated Data Platform, choosing to stick with its own home-spun platform developed over nearly a decade.
- Matt Hennessey, chief data and analytics officer at NHS Greater Manchester, said fully adopting the FDP would be a retrograde step because clinicians, data controllers, patients, and the public do not trust it.
- The NHS began rolling out the FDP in early 2024, and Palantir and the NHS claim it is already cutting wait times, shortening hospital stays, and maximizing use of operating theatres.
- The contract is set to run until 2031 unless the government exercises an early termination option next February.
Greater Manchester's Rejection
The health care board for Greater Manchester has repeatedly declined to adopt Palantir's FDP, choosing to stick with a home-spun platform developed over the best part of a decade. The board claims it doesn't need Palantir, that its own platform is functionally superior and more trusted by the public. Matt Hennessey, chief data and analytics officer at NHS Greater Manchester, told WIRED that even a technically strong platform will struggle to realize value if clinicians, data controllers, patients, or the public do not trust it. He added that fully adopting the FDP would be a retrograde step.
National Contract Debate
The Greater Manchester claim, disputed by Palantir and other FDP advocates, has fed into a national debate over whether the government should seize an opportunity next February to terminate the NHS contract early, instead of allowing it to run until 2031. The UK government has six months to decide whether to terminate the deal worth more than $400 million between the NHS and Palantir. The deal has become a flashpoint in the UK, drawing protests, petitions, parliamentary inquiries, and a reported rebellion among NHS workers. Other European nations, increasingly at loggerheads with the Trump administration, are also reevaluating their relationships with Palantir in a bid to minimize their dependence on US-made technology.
Platform Rollout and Claims
In 2023, the UK commissioned Palantir to develop a federated data platform that could ingest and organize the tangle of health data produced across the country. The NHS began to roll out the FDP in early 2024. According to Palantir and the NHS, the new system is already cutting wait times and the length of hospital stays, and maximizing the use of operating theatres. The platform consists of a national pool of health data meant to help identify care deficiencies, and a bunch of local databases that individual regions can use to perform analyses and develop tools specific to their needs—say, waitlist management or discharge planning. The various components all share the same underlying technology scaffolding, in theory making it possible for tools developed in one corner of the country to be readily adopted in another.
1 source
Greater Manchester rejects Palantir NHS platform, fueling debate over $400M contract
